Baird analyst Andrew Wittmann maintains MasTec (NYSE:MTZ) with a Outperform and raises the price target from $111 to $120.
Tenon Medical Is Seeking Withdrawal Of The Registration Statement Because It No Longer Wishes To Conduct A Public Offering Of Its Securities At This Time
On February 8, 2023, Tenon Medical, Inc. (the “Company”), initially filed a Registration Statement on Form S-1 (File No. 333-269653) (together with the exhibits and amendments thereto, the “Registration
